A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology

VanD-mediated glycopeptide resistance has been reported for an isolate of E nterococcus faecium, BM4339. Three clinical isolates of vancomycin-resistan t E. faecium collected from 3 patients during a 6-week period in 1993 had a gar dilution MICs of vancomycin and teicoplanin of 128 and 4 mu g/mL, respe ctively. Polymerase chain reaction (PCR) using degenerate primers complemen tary to genes encoding D-Ala-D-X ligases yielded a 630-bp product that was similar to the published partial sequence of vanD. By use of inverse PCR, v anD, vanH(D), and two partial flanking open-reading frames were sequenced. The deduced amino acid sequence of VanD showed 67% identity with VanA and V anB, vanD appeared to be located on the chromosome and was not transferable to other enterococci, The 3 isolates were indistinguishable by pulsed-fiel d gel electrophoresis and differed from BM4339. No other isolates carrying vanD were found in a subset of 875 recent US isolates of vancomycin-resista nt enterococci.